Drugs / Esketamine Nasal Product
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05603104 | Apr 2025 → Jun 2028 expected | bipolar depression, major depressive disorder, schizophrenia | Dr. Inge Winter | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Esketamine Nasal Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05603104 ↗ |
| Route | Intranasal | “esketamine nasal spray” NCT05603104 ↗ |